20696 Insurance Policy Changes

CPT 20696, in plain terms, covers Application of a multiplane unilateral external fixation system with stereotactic computer-assisted adjustment, such as a spatial frame, including imaging and the initial alignment and adjustment schedule. CPT 20696 is referenced in 4 tracked payer policy changes from Regence BlueShield and Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for CPT 20696 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Official descriptor: CPT 20696 on AAPC

Regence BlueShield · Effective Jan 1, 2027Medium impact
Bone Lengthening (Distraction Osteogenesis)
Bone lengthening (distraction osteogenesis) may be considered medically necessary when the criteria are met. Those criteria require a congenital or post-traumatic limb length discrepancy or an angular deformity of the arm, forearm, thigh or leg, plus one or more listed indications, including fracture nonunion or malunion of a long bone, lengthening of an amputation stump needed for a prosthesis fit, a leg length discrepancy greater than 6 cm, or bone defects with or without deformities. Bone lengthening is considered not medically necessary when these criteria are not met for indications other than short stature, and it is considered cosmetic when done solely to alter short stature. This policy takes effect January 1, 2027.
Aetna · Identified Aug 14, 2026Medium impact
Distraction Osteosynthesis (CPB 0220, reviewed 2026-04-09)
Aetna considers the Ilizarov method for distraction osteosynthesis medically necessary for members with an angular or rotational deformity of a long bone, a bone defect, or a limb length discrepancy who also meet one of the listed selection criteria, such as a leg length discrepancy of more than 4 cm, an arm length discrepancy of more than 5 cm, or a long bone fracture not healed in 6 or more months after electrical stimulation and bone grafting have failed. The PRECICE intramedullary limb lengthening system is considered medically necessary for lengthening the tibia and femur in persons with a leg length discrepancy of more than 4 cm. Ilizarov use for other indications, the intramedullary skeletal kinetic distractor, pulsed ultrasound as an adjuvant therapy, and Phenix nails are considered experimental, investigational or unproven, and Ilizarov use to correct short stature is considered cosmetic.
Aetna · Identified Aug 14, 2026Medium impact
Distraction Osteogenesis for Craniofacial Defects (CPB 0549, reviewed 2026-07-30)
Aetna considers distraction osteogenesis medically necessary to correct functional impairments from cleft lip and palate, hemifacial microsomia (Pruzansky Grade I and IIa mandibular deformity), severe congenital mandibular deficiency needing lengthening of more than 10 mm, severe micrognathia with airway obstruction (such as Pierre Robin or Treacher Collins syndrome), a short mandibular ramus, non-syndromic coronal or sagittal craniosynostosis, syndromic craniosynostosis (Apert, Crouzon, and Pfeiffer syndromes), and a narrow mandible or maxilla that needs widening. Other congenital craniofacial anomalies may be considered after review by Aetna's Oral and Maxillofacial Surgery Unit when distraction can uniquely produce a degree of improvement unavailable with other standard techniques. Distraction osteogenesis for acquired craniofacial defects, obstructive sleep apnea, and other craniofacial indications is considered experimental, investigational, or unproven, and it is considered cosmetic when done solely to improve appearance.
Aetna · Identified Aug 13, 2026Medium impact
Cranial Remodeling (CPB 0379, reviewed 2026-05-26)
Cranial remodeling bands or helmets are considered medically necessary orthoses for moderate-to-severe positional head deformities associated with premature birth, restrictive intra-uterine positioning, cervical abnormalities, birth trauma, torticollis and sleeping positions in children, when banding starts at 3 to 12 months of age, a 2-month trial of repositioning has failed and is judged unlikely to work, and anthropometric data or medical notes document the asymmetry. Banding after surgery for synostotic plagiocephaly is considered medically necessary to correct continued asymmetry, and a trial of conservative therapy is not needed in that case, while a second band or helmet is medically necessary only under the listed conditions and bands are contraindicated after 2 years of age or in unshunted or uncontrolled hydrocephalus. Use for persons who do not meet these criteria is considered cosmetic, and banding without surgery for synostotic plagiocephaly, pre-operative molding helmet therapy for sagittal craniosynostosis, banding for calcified cephalohematoma, and polycaprolactone mesh in pediatric cranial vault remodeling are considered experimental, investigational or unproven.

Watch 20696

Get one email when a payer policy names 20696, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

REFERENCE DATA

Payers with rules2

Payers requiring prior auth2

CalViva Health · Effective December 31, 2025
Prior authorization required
CalViva Health CMS-0057-F prior authorization requirements
Community Health Plan of Imperial Valley · Effective December 31, 2025
Prior authorization required
Community Health Plan of Imperial Valley CMS-0057-F prior authorization requirements

FREQUENTLY ASKED QUESTIONS

Does CalViva Health require prior authorization for 20696?

CalViva Health lists 20696 on CalViva Health CMS-0057-F prior authorization requirements for medicaid managed plans (list dated December 31, 2025). Verify with the payer before scheduling.

Does Community Health Plan of Imperial Valley require prior authorization for 20696?

Community Health Plan of Imperial Valley lists 20696 on Community Health Plan of Imperial Valley CMS-0057-F prior authorization requirements for medicaid managed plans (list dated December 31, 2025). Verify with the payer before scheduling.

What insurance policy changes affect CPT 20696?

There are 4 tracked policy changes affecting CPT 20696, including updates from Regence BlueShield, Aetna. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for CPT 20696?

Payers that have issued tracked updates for CPT 20696 include: Regence BlueShield, Aetna.

How do I get notified when CPT 20696 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to CPT 20696. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Why do payers change policies for CPT 20696?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

See every payer rule for 20696

Prior authorization lists, coverage criteria, NCCI edits and Medicare coverage articles for 20696 in one place.

See every payer rule

All billing codes J3590 C9399 J3490 99215 99213 99202

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

Bone Lengthening (Distraction Osteogenesis)

Distraction Osteosynthesis (CPB 0220, reviewed 2026-04-09)

Distraction Osteogenesis for Craniofacial Defects (CPB 0549, reviewed 2026-07-30)

Cranial Remodeling (CPB 0379, reviewed 2026-05-26)

Prior authorization required